Products & Services · Revenue

SET — Revenue

Zimmer Biomet Holdings SET — Revenue decreased by 4.3% to $562.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.5%, from $470.50M to $562.20M. Over 4 years (FY 2021 to FY 2025), SET — Revenue shows an upward trend with a 5.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Revenue

How to read this metric

An increase suggests strong market penetration and demand for the company's specialized surgical portfolio, while a decrease may indicate competitive pressure or reduced surgical procedure volumes in these categories.

Detailed definition

This metric represents the total net sales generated by the Sports Medicine, Extremities, Trauma, and Other (SET) busine...

Peer comparison

Peers in the medical device sector typically report similar segment-level revenue figures, often categorized by surgical specialty or product modality, allowing for benchmarking against competitors with comparable orthopedic portfolios.

Metric ID: zbh_segment_set_revenue_from_contract_with_customer_excluding_assessed_tax

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$462.10M$437.60M$410.50M$416.80M$446.40M$409.40M$424.10M$433.40M$442.70M$423.20M$453.30M$452.60M$469.50M$454.20M$489.30M$470.50M$550.60M$541.50M$587.60M$562.20M
QoQ Change-5.3%-6.2%+1.5%+7.1%-8.3%+3.6%+2.2%+2.1%-4.4%+7.1%-0.2%+3.7%-3.3%+7.7%-3.8%+17.0%-1.7%+8.5%-4.3%
YoY Change-3.4%-6.4%+3.3%+4.0%-0.8%+3.4%+6.9%+4.4%+6.1%+7.3%+7.9%+4.0%+17.3%+19.2%+20.1%+19.5%
Range$409.40M$587.60M
CAGR+4.2%
Avg YoY Growth+7.0%
Median YoY Growth+5.2%

Frequently Asked Questions

What is Zimmer Biomet Holdings's set — revenue?
Zimmer Biomet Holdings (ZBH) reported set — revenue of $562.20M in Q1 2026.
How has Zimmer Biomet Holdings's set — revenue changed year-over-year?
Zimmer Biomet Holdings's set — revenue increased by 19.5% year-over-year, from $470.50M to $562.20M.
What is the long-term trend for Zimmer Biomet Holdings's set — revenue?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's set — revenue has grown at a 5.6% compound annual growth rate (CAGR), from $1.73B to $2.15B.
What does set — revenue mean?
The total net revenue earned from the sale of sports medicine, extremities, and trauma surgical products.